Hydroxyurea trials for Sickle cell disease

All Hydroxyurea trials · All Sickle cell disease trials

Phase breakdown

Recruiting trials studying Hydroxyurea for Sickle cell disease

• A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
  NCT05953584 · Phase: Phase 2 · Ages: 12 Years to 16 Years · Sex: All (male and female) · 9 locations
• Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
  NCT07616154 · Phase: Phase 2 · Ages: Up to 22 Years · Sex: All (male and female) · 1 location
• Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
  NCT05285917 · Phase: Phase 3 · Ages: 6 Months to 12 Years · Sex: All (male and female) · 1 location
• Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
  NCT01962415 · Phase: Phase 2 · Ages: 2 Months to 55 Years · Sex: All (male and female) · 2 locations
• Stroke Prevention in Nigeria 2 Trial
  NCT06526117 · Phase: Phase 4 · Ages: 5 Years to 12 Years · Sex: All (male and female) · 2 locations
• T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
  NCT03653338 · Phase: Phase 1, Phase 2 · Ages: 5 Years to 40 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Hydroxyurea for Sickle cell disease?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.